| Zhang, Bo |
NCT06263348: A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes |
|
|
| Recruiting | 4 | 2000 | RoW | Dorzagliatin tablets | Hua Medicine Limited, Shanghai Branch, KunTuo Medical Research and Development (Beijing) Co., Ltd. | Type2diabetes | 04/26 | 04/26 | | |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED ) |
|
|
| Recruiting | 4 | 9000 | RoW | Aspirin 100 mg Oral Tablet, Matching Placebo | Guangdong Provincial People's Hospital, The George Institute | CKD (Chronic Kidney Disease) Stage 5D | 09/26 | 12/26 | | |
| Not yet recruiting | 3 | 8862 | RoW | Colchicine 0.5 mg, no other name, Colchicine 0.375 mg, Placebo | Wuhan Union Hospital, China | Coronary Heart Disease, Percutaneous Coronary Intervention, Colchicine | 03/28 | 08/28 | | |
RIDER, NCT05794971: Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases |
|
|
| Recruiting | 3 | 126 | RoW | Regorafenib and DIBIRI, Drug: Irinotecan, Procedure: TACE, Device: drug eluting-bead, Regorafenib | Sun Yat-sen University | Colorectal Cancer Liver Metastases, Regorafenib | 03/27 | 03/28 | | |
Peri-E, NCT06688656: Neoadjuvant Chemotherapy Sequentially Combined with Sintilimab in Resectable EGFR-Mutant NSCLC |
|
|
| Not yet recruiting | 2 | 30 | RoW | Pemetrexed 500 mg/m2, carboplatin, Sintilimab | Shanghai Chest Hospital | Lung Cancer | 03/26 | 03/28 | | |
| Recruiting | 1/2 | 300 | RoW | OH2 injection, with or without irinotecan or HX008 | Binhui Biopharmaceutical Co., Ltd. | Solid Tumor, Gastrointestinal Cancer | 08/25 | 08/25 | | |
NCT04762602: A Study of HMPL-306 in Advanced Solid Tumors With IDH Mutations |
|
|
| Active, not recruiting | 1 | 90 | Europe, US | HMPL-306 | Hutchmed | Isocitrate Dehydrogenase Gene Mutation | 03/25 | 09/25 | | |
NCT04936178: A Study of NB003 in Patients With Advanced Malignancies |
|
|
| Recruiting | 1 | 258 | Europe, US, RoW | NB003 tablets | Ningbo Newbay Technology Development Co., Ltd | Advanced Solid Tumor | 07/25 | 12/25 | | |
NCT04121520: Perioperative Care of HVPG Measurement (CHESS1904): An International Multicenter Survey |
|
|
| Completed | N/A | 200 | Europe, Japan, RoW | Questionnaire | Hepatopancreatobiliary Surgery Institute of Gansu Province, LanZhou University, Shandong Provincial Hospital, Xingtai People's Hospital, Zhejiang University, Ankara University, Chiba University Graduate School of Medicine, Universitas Indonesia, Cipto Mangunkusumo National General Hospital, S. Orsola-Malpighi Hospital, University of Bologna, Universidade Federal de Pernambuco, Hanyang University College of Medicine | Portal Hypertension, Cirrhosis, Liver | 08/21 | 08/22 | | |
COOPERATION, NCT04912518: Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction |
|
|
| Recruiting | N/A | 250 | RoW | Dexmedetomidine (DEX), Placebo (Saline) | Harbin Medical University, Yangtze River Pharmaceutical Group Co., Ltd. | ST-segment Elevation Myocardial Infarction (STEMI), Percutaneous Coronary Intervention, Cardioprotection | 12/24 | 12/25 | | |
NCT05375123: Reference Range for Tissue Motion Tracking of Mitral Annulus Displacement in Chinese Han Singleton Pregnancies |
|
|
| Recruiting | N/A | 660 | RoW | Ultrasound image acquisition | First Hospital of China Medical University | Pregnancy | 06/23 | 06/24 | | |
NCT05547841: Normal Reference Value for Echocardiography in Chinese Han Pregnancies |
|
|
| Recruiting | N/A | 680 | RoW | Echocardiography acquisition | First Hospital of China Medical University | Pregnancy | 08/23 | 08/24 | | |
NCT06282796: Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy |
|
|
| Recruiting | N/A | 600 | RoW | Echocardiography | First Hospital of China Medical University | Breast Cancer | 12/26 | 12/28 | | |
NCT06229197: Billroth II With Braun Anastomosis After Radical Distal Gastrectomy for Gastric Cancer |
|
|
| Not yet recruiting | N/A | 176 | NA | Billroth II reconstruction, Braun Anastomosis | Sichuan University | Gastric Cancer, Surgery, Anastomosis, Gastrostomy | 12/26 | 12/27 | | |
NCT06365502: Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial) |
|
|
| Recruiting | N/A | 1860 | RoW | Drug-coated balloon, Guideline-directed medical treatment | Harbin Medical University, Shanghai Shenqi Medical Technology Co., Ltd | Acute Coronary Syndrome (ACS) | 12/27 | 12/30 | | |
NCT06455644: Accuracy of LAA Occluder Size Selection: CT vs. DSA During Combined AF Ablation and LAA Occlusion |
|
|
| Recruiting | N/A | 238 | RoW | CT group, DSA group | First Affiliated Hospital of Shantou University Medical College | Atrial Fibrillation, Arrhythmias, Cardiac, Heart Diseases, Cardiovascular Diseases | 10/26 | 07/31 | | |
NCT05649488: Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus |
|
|
| Recruiting | N/A | 184 | RoW | Intracoronary lithotripsy balloon catheter and Intracoronary lithotripsy apparatus, Dragonfly Opstar Imaging Catheter | Shanghai Bluesail Boyuan Medical Technology Co., Ltd. | Coronary Artery Disease, Intravascular Lithotripsy | 12/24 | 09/25 | | |
NCT06794801: Evaluating the Safety and Efficacy of Drug-Coated Autoperfusion Balloons Versus Conventional Drug-Coated Balloons Guided by IVUS-OCT Multimodal Imaging for Treating Acute Myocardial Infarction: OPERA-AMI Study |
|
|
| Not yet recruiting | N/A | 134 | RoW | Drug Coated Autoperfusion Balloon Dilatation Catheter（DCAB）, Conventional Drug coated balloon (DCB), Bingo® PTCA Drug Delivery System | LanZhou University | ST Segment Elevation Myocardial Infarction (STEMI) | 12/26 | 12/30 | | |
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | N/A | 300 | RoW | | Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Hepatocellular Carcinoma | 03/26 | 03/26 | | |
BEST-BAO, NCT05631847: Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke |
|
|
| Recruiting | N/A | 336 | RoW | Endovascular treatment, Intravenous thrombolysis (Alteplase) | Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital | Acute Ischemic Stroke, Basilar Artery Occlusion, Thrombosis, Alteplase, Endovascular Treatment | 01/27 | 05/27 | | |
| Li, Hao |
NCT06697366: Liposomal Irinotecan Combined with Sintilimab for Second-line Treatment of Progressive Gastric Cancer |
|
|
| Not yet recruiting | 2 | 27 | NA | Irinotecan liposome injection Ⅱ, Sintilimab | Ruijin Hospital | Gastric Cancer | 05/26 | 11/26 | | |
NCT05079022: ctDNA-MRD Based Adjuvant Targeted Therapy for EGFR Positive Stage I Lung Adenocarcinomas |
|
|
| Not yet recruiting | 1/2 | 50 | RoW | Furmonertinib, AST2818, AST5902 | Peking University People's Hospital, Beijing CSCO-Allist Cancer Research Foundation, Shanghai Allist Pharmaceutical Technology Co., Ltd., Guangzhou Burning Rock Medical Examination Institute Co., Ltd. | Adenocarcinoma of Lung | 03/23 | 09/24 | | |
NCT04461652: The Effect of a Combined Drainage Strategy in Uniportal Upper Lung Lobectomy |
|
|
| Recruiting | N/A | 400 | RoW | prophylactic air-extraction catheter drainage | Tongji University | Carcinoma, Non-Small-Cell Lung | 11/21 | 03/22 | | |
NCT05204901: Using Magnetic Field Tracking to Confirm Nasogastric Tube Placement at Point of Care |
|
|
| Completed | N/A | 10 | RoW | Insertion and withdrawal of a magnetic-tipped wire into the lumen of the nasogastric tube for tracking of its position | Tan Tock Seng Hospital, Nanyang Technological University, Woodlands Health Campus | Enteral and Supplement Feeds Adverse Reaction, Gastrointestinal Diseases, Esophagus Disorder | 12/22 | 12/22 | | |
NCT03613272: The Curative Effect of Extended Thymectomy Performed Through Subxiphoid-right VATS Approach With Elevation of Sternum |
|
|
| Recruiting | N/A | 200 | RoW | Subxiphoid approach extended thymectomy by VATS, Intercostal approach extended thymectomy by VATS | Jiang Fan | Thymoma, Myasthenia Gravis, Mediastinal Tumor | 07/23 | 12/23 | | |
NCT05274789: Effect of Intraoperative Dexmedetomidine on Postoperative Delirium in Elderly Patients Undergoing Robot-assisted Pancreaticoduodenectomy: a Randomized Controlled Study |
|
|
| Recruiting | N/A | 300 | RoW | Dexmedetomidine, Saline | Chinese PLA General Hospital, Beijing Tiantan Hospital | Delirium in Old Age | 04/24 | 04/24 | | |
NCT05436964: Effect of Intraoperative Dexmedetomidine on Postoperative Delirium in Elderly Patients Undergoing Major Abdominal Surgery |
|
|
| Recruiting | N/A | 300 | RoW | saline, Dexmedetomidine | Chinese PLA General Hospital, Beijing Tiantan Hospital | Delirium in Old Age | 06/24 | 06/24 | | |
NCT06601075: The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases) |
|
|
| Recruiting | N/A | 30 | RoW | | Ruijin Hospital | Advanced Colorectal Cancer | 03/26 | 03/29 | | |
| Chen, Liangfeng |
NCT04848753: Perioperative Toripalimab (JS001) Combined With Neoadjuvant Chemotherapy in Patients With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma |
|
|
| Active, not recruiting | 3 | 663 | RoW | Toripalimab combined with cisplatin and paclitaxel, Placebo combined with cisplatin and paclitaxel | Shanghai Junshi Bioscience Co., Ltd. | Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma | 05/27 | 05/27 | | |
| Xia, Jumei |
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED ) |
|
|
| Recruiting | 4 | 9000 | RoW | Aspirin 100 mg Oral Tablet, Matching Placebo | Guangdong Provincial People's Hospital, The George Institute | CKD (Chronic Kidney Disease) Stage 5D | 09/26 | 12/26 | | |
